Samsung Biologics is a contract development and manufacturing company for the biopharmaceutical industry, based in Incheon, South Korea. It works with drug developers and pharmaceutical companies around the world, offering services that cover cell line development, process development and the large-scale production of biologic medicines. Its plants are built to make therapeutic proteins and other biologics on behalf of clients, so the company operates as a manufacturing partner rather than as a seller of its own branded medicines.
On this site Samsung Biologics Co Ltd appears as a stock on the Korea Exchange (Korea), code 207940, with prices in South Korean won (KRW). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #244 of 934 on the Korea Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Korea yet.
TrendFair
64/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-9.6%
From 52-week high-30.1%
MomentumWeak
46/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-11.1%
6-month return-8.9%
12-month, skipping last month-23.2%
Stability (higher is calmer)Fair
61/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)43.8%
Worst drawdown, 1 year (smaller is calmer)-39.8%
LiquidityStrong
96/100
Trades actively.
See the numbers →
Avg daily value traded81,207.91M KRW
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Korea when fundamentals data for this market is added. All Korea stocks.
52-wk range 1,150,000.00 – 1,987,000.00Daily closes, split-adjusted
Signals
50-day average1,426,004.11
200-day average1,520,106.03
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)67,032.27
Technical summary
Daily
Neutral
5 bullish · 4 neutral · 7 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
1,361,500.0
Bullish
EMA 10
1,378,035.8
Bearish
SMA 20
1,337,460.3
Bullish
EMA 20
1,366,477.7
Bullish
SMA 50
1,426,004.1
Bearish
EMA 50
1,394,987.4
Bearish
SMA 100
1,414,242.1
Bearish
EMA 100
1,429,097.9
Bearish
SMA 200
1,520,106.0
Bearish
EMA 200
1,473,545.7
Bearish
Oscillators (daily)
RSI (14)
50.17
Neutral
MACD (12, 26)
1,051.8
Bullish
Momentum (12)
12.72
Bullish
Stochastic %K (14)
66.08
Neutral
Williams %R (14)
-33.92
Neutral
CCI (20)
47.20
Neutral
Pivot points (classic, last session)
S3
1,253,666.7
S2
1,303,333.3
S1
1,338,666.7
Pivot
1,388,333.3
R1
1,423,666.7
R2
1,473,333.3
R3
1,508,666.7
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in KRW. Educational only, not financial advice.
